OTC market in Central and Eastern Europe expected to grow by 9% per annum between 2011 and 2013
Half of market value generated by Russia
As in previous years, in 2010, around half of market value was generated by Russia. In 2010 Poland was the second largest OTC market in the region, with a share as a proportion of total sales value of around 23%. Ukraine accounted for approximately 7% of all OTC business on the CEE market.
“Even if the less substantial increase in sales in 2009 in Ukraine is taken into account, the country was the most rapidly developing OTC market in the region in 2009-2010, in terms of CAGR (compound annual growth rate). Russia and Bulgaria also witnessed average annual growth rates of 9-10% during this period” says Agnieszka Skonieczna, PMR Senior Pharmaceutical Market Analyst and the report co-author.
Ukraine the most promising OTC market in the region
According to PMR forecasts, Ukraine and Bulgaria will remain the most rapidly developing OTC markets in the region between 2011 and 2013.
It is worthy of note that if the ban on the advertising of OTC products in Ukraine is introduced, there could be a reduction in the market growth rate of a few percentage points each year. There has recently been a great deal of discussion in Ukraine about the proposed Act No. N7007, the “Act banning the advertising of pharmaceutical drugs”, which passed its first reading in parliament in December 2010. The government planned to schedule the second reading by the end of 2011. The act, as its name suggests, stipulates that the advertising of all products (including dietary supplements) will be banned in the mass media. Information on drugs will be allowed exclusively in specialist magazines devoted to medical facilities and doctors, and in materials available at seminars, conferences and symposiums devoted to the subject of medicine.
M&A activity in progress
Few important acquisitions of OTC companies or their portfolios have taken place in CEE in the last year. In May 2011, for example, Johnson & Johnson, through Cilag, bought the OTC business of the Indian company JB Chemicals & Pharmaceuticals in Russia and other CIS countries. JB’s OTC brands were sold on a slump sale basis, and this included trademarks, brand names, patents, registrations and domain names. The transaction was worth $260m (€196m).
The Italian Angelini Group strongly developed its OTC portfolio in the region. In November 2010 Medagro Internation, part of Angelini, acquired six of GSK’s OTC drugs and dietary supplements in Poland, becoming their exclusive owner and distributor. Later, in the summer of 2011, Angelini took over the product portfolio of CSC Pharmaceuticals Romania. 75% of the portfolio consists of Rx drugs, and 25% of OTC drugs.
Slovakia to introduce non-pharmacy sales?
Russia, Ukraine, and Slovakia are the only CEE (Central and Eastern European) countries in which non-pharmacy sales of pharmaceuticals are not allowed. A proposal by the Russian Ministry of Industry and Trade to allow such sales was rejected by the Ministry of Health and Social Development and any possible changes in Ukraine are more likely to focus on reducing the number of people practising self-medication. Now, it seems, Slovakia is seriously considering changes in legislation in this area.
A government proposal in Slovakia’s National Reform Programme 2011 addresses the issue of OTC sales. With the intention of stimulating competition and reducing the prices of OTC medicine, the Slovak Finance Ministry intends to initiate a debate on the introduction of OTC medicine sale at places other than pharmacies. However, the Slovak Chamber of Pharmacists and the country’s Health Ministry are opposed to such a change. The National Reform Programme covers many areas and is to be implemented by the Slovak ruling coalition by the time of new parliamentary elections in 2014.
This press release is based on information contained in the latest PMR report entitled “OTC market in Central and Eastern Europe 2011. Comparative analysis and development forecasts for 2011-2013” http://www.pmrpublications.com/product/OTC-market-in-Central-and-Eastern-Europe-2011
For more information on the report please contact:
tel. /48/ 12 618 90 00
PMR www.pmrcorporate.com is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release OTC market in Central and Eastern Europe expected to grow by 9% per annum between 2011 and 2013 here
News-ID: 199757 • Views: 1462
More Releases from PMR Ltd
60% of Polish SMEs use IT services
Approx. 60% of small and medium sized enterprises use IT services in Poland. Some 30% of SMEs declare to employ people responsible for IT. The number of portable computers used by SMEs has been growing. On average, there are five such computers per one SME. The proportion of companies which use EU funds to finance ICT development has gone down over the last two years. Use of IT services According to the
Ukrainian IT industry to keep on growing in 2012-2013
In the last two years Ukrainian IT market has been recovering after a sharp decline experienced in 2009. The market will continue to record double digit growth rates in 2012-2013. The macroeconomic and political situation will remain of crucial importance in the country. Current situation and key trends According to the latest report “IT market in Ukraine 2012. Development forecasts for 2012-2017” published by PMR, a market research company, the total
Retail grocery market to provide €117bn in 2014 in the CE region
PMR estimates that in 2011 the grocery market in six Central European (CE) countries was worth nearly €107bn, 2.8% more than the previous year when expressed in local currencies. The increase was generated foremost by the discount stores and supermarket segments, and was driven by the skyrocketing prices of foodstuffs. Schwarz Group, which operates the Lidl and Kaufland chains, is a leading grocery player in the CE region – as
Hungarian construction market to recover in 2013-2014
After a poor 2009-2012 for the Hungarian construction industry, from 2013 a visible market recovery is expected. The growth in 2013-2014 will result from the intense execution of EU co-financed infrastructure investments as well as some revival in building construction, particularly in non-residential buildings. According to the research company PMR’s latest report, entitled “Construction sector in Hungary 2012 – Development forecasts for 2012-2014”, weak macroeconomic environment, falling investment demand and poor
More Releases for OTC
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
Foods Matrix Inc. Exploring OTC Markets Listing
Foods Matrix Inc. (FMI), a US based food processing startup is exploring options to list on the OTC Markets. FMI is in talks to acquire a distressed food processing unit in the state of Punjab, India for US $3 million. The deal may be sealed by the end of November, 2018, post completion of the ongoing due diligence. FMI may initially quote on the pink sheet segment of the OTC Markets
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
7 Key Projections for OTC Analgesics Market
The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Request For Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years. Various off-label drugs including tricyclic antidepressants, antihistamines,
OTC Drug Market Report Research : 2017
Reports And Markets Publish a New Market Research Report On –" OTC Drug Market Report Research : 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-otc-drug-market-report-2017-1541262 In this report, the Asia-Pacific OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several